View in EDS PDF Full Text

Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.

Saved in:
Bibliographic Details
Title: Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.
Authors: Fife D; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA., Voss EA; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA., Hardin J; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA., Rofael H; Established Products, Janssen Research & Development, LLC, Titusville, NJ, USA., Solomon ID; Established Products, Janssen Research & Development, LLC, Titusville, NJ, USA., Ryan PB; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA., Stang P; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA.
Source: Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2021 Sep; Vol. 41 (3), pp. 385-392. Date of Electronic Publication: 2021 Jun 28.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101719700 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2574-173X (Electronic) Linking ISSN: 2574173X NLM ISO Abbreviation: Neuropsychopharmacol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34180161
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fife+D%22">Fife D</searchLink>; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Voss+EA%22">Voss EA</searchLink>; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Hardin+J%22">Hardin J</searchLink>; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Rofael+H%22">Rofael H</searchLink>; Established Products, Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Solomon+ID%22">Solomon ID</searchLink>; Established Products, Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Ryan+PB%22">Ryan PB</searchLink>; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Stang+P%22">Stang P</searchLink>; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101719700%22">Neuropsychopharmacology reports</searchLink> [Neuropsychopharmacol Rep] 2021 Sep; Vol. 41 (3), pp. 385-392. <i>Date of Electronic Publication: </i>2021 Jun 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101719700 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2574-173X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222574173X%22">2574173X </searchLink><i>NLM ISO Abbreviation: </i>Neuropsychopharmacol Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34180161
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/npr2.12191
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 385
    Titles:
      – TitleFull: Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fife D
      – PersonEntity:
          Name:
            NameFull: Voss EA
      – PersonEntity:
          Name:
            NameFull: Hardin J
      – PersonEntity:
          Name:
            NameFull: Rofael H
      – PersonEntity:
          Name:
            NameFull: Solomon ID
      – PersonEntity:
          Name:
            NameFull: Ryan PB
      – PersonEntity:
          Name:
            NameFull: Stang P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2021 Sep
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2574-173X
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Neuropsychopharmacology reports
              Type: main
ResultId 1